Doximity (DOCS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
15 Jul, 2026Executive summary
Annual Meeting scheduled for August 27, 2026, to be held virtually, with voting available online, by phone, mail, or during the meeting.
Record date for voting eligibility is July 2, 2026; both Class A and Class B common stockholders may vote as a single class, with Class B shares carrying 10 votes per share.
Proposals include election of two Class II directors, ratification of Deloitte & Touche LLP as auditor, and a non-binding advisory vote on executive compensation.
Board recommends voting FOR all proposals.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of two Class II directors (Kevin Spain and Timothy Cabral), (2) ratification of Deloitte & Touche LLP as independent auditor for FY2027, and (3) advisory approval of executive compensation (Say-on-Pay).
Plurality voting applies for directors; majority required for auditor ratification and Say-on-Pay.
Shareholder proposals for the 2027 meeting must be received between March 18 and April 17, 2027.
Board of directors and corporate governance
Board is divided into three staggered classes; majority are independent per NYSE standards.
Board committees (audit, compensation, nominating/governance) are fully independent and meet regularly.
Board leadership is combined with CEO as chair; annual self-evaluations and access to independent advisors are in place.
Code of conduct and insider trading policy apply to all directors and employees.
Latest events from Doximity
- Virtual meeting to vote on directors, auditor, and executive pay, with board support for all.DOCS
Proxy filing15 Jul 2026 - 20% revenue growth, record margins, and strong AI-driven engagement set up for cautious FY26.DOCS
Q4 20259 Jul 2026 - Q3 revenue up 25% with margin expansion, record engagement, and ongoing share repurchases.DOCS
Q3 20258 Jul 2026 - Record free cash flow, strong AI adoption, and 13% revenue growth set up modest FY27 outlook.DOCS
Q4 202620 May 2026 - Delivers AI-powered workflow tools to 85%+ of U.S. physicians, achieving 22% revenue CAGR.DOCS
Investor presentation13 May 2026 - Revenue up 10% to $185.1M, strong margins, AI acquisition, and $500M buyback authorized.DOCS
Q3 202616 Apr 2026 - AI-powered platform with 85% physician reach, rapid revenue growth, and strong market penetration.DOCS
Investor presentation25 Feb 2026 - Revenue up 17% to $126.7M, profits and margins rose, and FY25 guidance was raised.DOCS
Q1 20251 Feb 2026 - Q2 revenue up 20% to $137M, net income up 44%, and margins hit records on strong platform growth.DOCS
Q2 202515 Jan 2026